EKSO Q2 2019 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q2 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+9.9% YoY

Gross Profit

$2M47.8% margin

Operating Income

-$5M-156.3% margin

Net Income

-$3M-94.0% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

-9.8%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$605,000

Balance Sheet

Total Assets

$26M

Total Liabilities

$20M

Stockholders' Equity

$5M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+9.9%
Gross Profit	$2M	$967,000	+61.3%
Operating Income	-$5M	-$7M	+29.0%
Net Income	-$3M	-$8M	+61.6%

Revenue Segments

Product

$3M77%

Service

$671,00021%

Product and Service, Other

$60,0002%

Collaborative Arrangements

$8,0000%

Geographic Segments

UNITED STATES

$2M72%

Non-US

$905,00028%